Exercise is known as one of the best weapons in limiting the effects of the disease and creating dopamine that is low for ...

Parkinson’s is the fastest growing neurological condition in the world and affects around 153,000 people in the UK.

More than 100,000 Canadians currently live with Parkinson's disease. A novel drug molecule being studied by researchers from ...

Higher exposure to air pollution increases the risk for Parkinson's disease (PD), according to a study published online Sept.

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a new study.

Sep. 18, 2024 — A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a new ... Researchers Develop Analytical Pipeline to Identify ...

A novel drug molecule could potentially lead to new treatments to prevent Parkinson's disease in younger patients, according to new research.

A new study adds to a growing body of evidence that Parkinson’s disease, long believed to have its origins in the brain, may begin in the gut. Gastrointestinal problems are common in patients ...

Paraquat exposure and its link to Parkinson’s disease is leading to policy battles within California and nationwide.

Parkinson's disease (PD) affects about 2% of people aged 70 and older. Over the next 20 years, the number of individuals with ...

Parkinson’s disease and Alzheimer’s disease risk are lowered in people who take a type of type 2 diabetes drug, a study from South Korea has shown. Published in Neurology, the medical journal ...

A specific type of diabetes medication has been associated with a lower risk of dementia, Alzheimer's and Parkinson's disease in a study published today. The South Korean study followed 358,862 ...